Dead space full details for md exams 10 marks

Reading File

Finding Sources

Reading File

Loading Image

Reading File

In respiratory medicine exam paper

I have all the content needed from the previous research. Let me now compile this into a complete, exam-ready answer.

Dead Space — Complete Answer for MD Respiratory Medicine Exam (10 Marks)

Definition

Dead space is the volume of the respiratory system that is ventilated but does not participate in gas exchange with pulmonary capillary blood. It represents "wasted ventilation."

Dead space is a general term that refers to both the anatomic dead space of the conducting airways and a functional, or physiologic, dead space. - Costanzo Physiology 7th Ed.

Classification of Dead Space

1. Anatomic Dead Space

The volume of gas contained in the conducting airways: nose/mouth, pharynx, larynx, trachea, bronchi, and bronchioles (up to, but not including, respiratory bronchioles and alveoli)
These structures conduct air but have no alveolar-capillary membrane for gas exchange
Normal value: ~150 mL in a healthy adult male (approximately 1 mL per pound of ideal body weight)
Increases slightly with large inspirations (radial traction on bronchi expands them)
Women have smaller anatomic dead space than men due to smaller airway caliber
Increases slightly after age 50-60 years

Anatomic dead space diagram showing 150 mL conducting airway volume vs 350 mL alveolar volume in a 500 mL tidal breath

Fig: Of a 500 mL tidal volume, 150 mL fills the anatomic dead space; only 350 mL reaches the alveoli for gas exchange.

2. Alveolar Dead Space

Volume of gas reaching alveoli that are ventilated but not perfused (or inadequately perfused) by pulmonary capillary blood
Represents V/Q = infinity (ventilation present, perfusion absent)
Normally negligible in healthy individuals
Increases significantly in pathological states (e.g., pulmonary embolism, emphysema)

3. Physiologic (Total) Dead Space

Physiologic dead space = Anatomic dead space + Alveolar dead space

This is a functional measurement based on the lung's ability to eliminate CO₂
In healthy individuals: physiologic dead space ≅ anatomic dead space (alveolar dead space is negligible)
In disease: physiologic dead space can exceed anatomic dead space by up to 10-fold (1-2 L)
Normal ratio: VD/VT = ~0.3 (dead space is about one-third of tidal volume)

Measurement of Dead Space

A. Fowler's Method (Single-Breath N₂ Washout) — Measures Anatomic Dead Space

Procedure:

Patient takes a maximal inspiration of 100% O₂ from mid-inspiration
Then exhales steadily while expired N₂ concentration is continuously monitored

Four phases of the expired N₂ curve:

Phase	Description
Phase I	Pure dead space gas — no N₂ (O₂ that filled conducting airways)
Phase II	Mixture of dead space gas and alveolar gas — N₂ rises steeply
Phase III	Plateau of alveolar gas — relatively constant N₂ (slight positive slope)
Phase IV	N₂ rises sharply = closing volume (lower zone airways close)

Dead space volume = volume expired from peak inspiration to the midpoint of Phase II
The midpoint bisects Phase II such that the area "above" the curve equals the area "below" it

B. Bohr Equation — Measures Physiologic Dead Space

Based on the principle that all CO₂ in expired air comes from functioning (perfused) alveoli; dead space air contributes zero CO₂.

Derivation:

Total expired CO₂ = CO₂ from alveolar compartment + CO₂ from dead space

$$V_E \times F_{ECO_2} = V_A \times F_{ACO_2} + V_D \times F_{ICO_2}$$

Since F~~ICO₂~~ ≅ 0 (room air breathing), and substituting partial pressures, and since P~~aCO₂~~ ≅ P~~ACO₂~~:

$$\boxed{V_D = V_T \times \frac{P_{a}CO_2 - P_{\bar{E}}CO_2}{P_{a}CO_2}}$$

Where:

VD = physiologic dead space volume (mL)
VT = tidal volume (mL)
PaCO₂ = arterial blood PCO₂ (mm Hg) — used as a surrogate for alveolar PCO₂
PECO₂ = PCO₂ of mixed expired air (mm Hg) — collected over several breaths

Example (normal):

PaCO₂ = 40 mmHg, PECO₂ = 28 mmHg, VT = 500 mL
VD = 500 × (40 - 28)/40 = 500 × 0.30 = 150 mL

Extreme examples to understand the equation:

If dead space = 0: PECO₂ = PaCO₂ = 40 → fraction = 0 → VD = 0 ✓
If dead space = entire VT: no gas exchange → PECO₂ = 0 → fraction = 1 → VD = VT ✓

Key difference: Fowler's method measures anatomical dead space; the Bohr method measures physiological dead space. They yield the same result in healthy lungs. In pulmonary embolism, the Bohr method detects increased physiological dead space while Fowler's method does not. - Medical Physiology (Boron & Boulpaep)

Dead Space and Alveolar Ventilation

$$\dot{V}_A = (V_T - V_D) \times \text{Respiratory Rate}$$

Normal: (500 - 150) × 12 = 4,200 mL/min

Critical concept — Rapid shallow breathing vs. slow deep breathing:

Parameter	Rapid Shallow	Slow Deep
Rate	30/min	10/min
Tidal volume	200 mL	600 mL
Minute ventilation	6 L/min	6 L/min
Alveolar ventilation	(200-150)×30 = 1,500 mL/min	(600-150)×10 = 4,500 mL/min

Same minute ventilation, but 3x less alveolar ventilation with rapid shallow breathing — the dead space constitutes a much larger fraction of each small tidal breath.

Pathophysiology of Increased Dead Space

Causes of Increased Physiologic Dead Space

Category	Examples
Pulmonary vascular	Pulmonary embolism (classic), decreased cardiac output, vasoconstrictors
Parenchymal	Emphysema (destroyed alveolar walls + capillary beds), blebs, hyperinflation
Mechanical	Positive pressure ventilation (compresses alveolar vessels), PEEP
Anatomic	Tracheostomy (bypasses upper airway dead space but adds instrument dead space)

Mechanism of Increased Dead Space - V/Q Mismatch

Dead space = high V/Q units (V/Q → ∞)
Ventilated alveoli without perfusion cannot exchange O₂ or CO₂
The alveolar PCO₂ in these units falls to inspired air levels (~0 mmHg)
The alveolar PO₂ rises toward inspired levels (~150 mmHg)

Local Compensatory Mechanism

In the setting of increased dead space, local bronchoconstriction acts to normalize the V/Q ratio by redirecting ventilation away from underperfused regions.

Clinical Consequences of Increased Dead Space

1. Hypercapnia

Increased dead space reduces effective CO₂ elimination
Compensatory hyperventilation (increased minute ventilation) is the normal response
Hypercapnia does not develop until dead space exceeds ~50% of total lung volume, because the body can increase minute ventilation to compensate

2. Hypoxemia

Decreased PaO₂ related to dead space (V/Q > 1) generally improves with supplemental O₂ — this distinguishes it from shunt (V/Q = 0) which does not respond well to O₂

3. Increased work of breathing

Patient must increase total minute ventilation to maintain adequate alveolar ventilation
If ventilatory reserve is exceeded, respiratory muscle fatigue and respiratory failure ensue

VD/VT Ratio — Clinical Importance

Normal: 0.25 - 0.35 (25-35%)
In mechanically ventilated ICU patients: elevated VD/VT (>0.60) is associated with increased mortality in ARDS
Used to gauge severity of V/Q mismatch in respiratory failure
Requires arterial blood gas (for PaCO₂) and simultaneous mixed expired gas collection

Summary Table

Feature	Anatomic Dead Space	Alveolar Dead Space	Physiologic Dead Space
Location	Conducting airways	Non-perfused alveoli	Anatomic + Alveolar
Normal value	~150 mL (~1 mL/lb IBW)	~0 mL	~150 mL
Measurement	Fowler's method (N₂ washout)	Calculated	Bohr equation (CO₂ method)
V/Q	No perfusion, no ventilation exchange	V/Q = ∞	Combination
In disease	Minimally changed	Markedly increased	Markedly increased

Key Exam Points to Remember

Dead space = wasted ventilation (no gas exchange despite being ventilated)
Physiologic DS = Anatomic + Alveolar; in health, alveolar DS ≈ 0
Bohr equation uses arterial PCO₂ and mixed expired PCO₂ to calculate physiologic dead space
Fowler's method (N₂ single breath) measures anatomic dead space
Pulmonary embolism is the classic cause of increased alveolar dead space - Bohr detects it, Fowler does not
VD/VT normal = 0.3; rises significantly in pulmonary embolism, emphysema, ARDS
Rapid shallow breathing is highly inefficient because dead space is a larger fraction of each small tidal volume
Hypercapnia only occurs when dead space > 50% VT because hyperventilation normally compensates
Hypoxemia from dead space responds to O₂; hypoxemia from shunt does not
Local bronchoconstriction is the compensatory response to reduced perfusion (redirects ventilation)

Respiratory acidosis for md exams 10 marks answer full details

Finding Sources

Reading File

I now have comprehensive content from 6+ authoritative textbooks. Let me compile the full exam answer:

Respiratory Acidosis — Full Answer for MD Respiratory Medicine Exam (10 Marks)

Definition

Respiratory acidosis is a primary acid-base disorder characterized by a rise in arterial PCO₂ (hypercapnia) due to inadequate alveolar ventilation, resulting in a fall in arterial pH below 7.35.

The fundamental equation governing this process:

$$CO_2 + H_2O \underset{CA}{\rightleftharpoons} H_2CO_3 \rightleftharpoons H^+ + HCO_3^-$$

When CO₂ is retained, this reaction is driven to the right, generating excess H⁺ and lowering pH.

Henderson-Hasselbalch equation: $$pH = 6.1 + \log\frac{[HCO_3^-]}{0.03 \times PaCO_2}$$

Kassirer-Bleich approximation (clinical bedside use): $$[H^+] = 24 \times \frac{PaCO_2}{[HCO_3^-]}$$

Normal ABG Values (Reference)

Parameter	Normal Range
pH	7.35 - 7.45
PaCO₂	35 - 45 mmHg
HCO₃⁻	22 - 26 mEq/L
PaO₂	80 - 100 mmHg

In Respiratory Acidosis:

pH: ↓ (< 7.35)
PaCO₂: ↑ (primary disturbance)
HCO₃⁻: ↑ (compensatory)

Pathophysiology

Primary Mechanism

Any condition that reduces alveolar ventilation leads to CO₂ retention. The body generates ~200 mL/min of CO₂ through oxidative metabolism. When the lung cannot excrete this load, PaCO₂ rises.

Causes reduce ventilation through four main mechanisms:

Depression of the medullary respiratory center - reduces drive to breathe
Impaired neuromuscular transmission - reduces mechanical ability to ventilate
Airway obstruction - increases resistance, reduces effective ventilation
Impaired gas exchange - CO₂ cannot exit pulmonary capillary blood into alveolar air

Sequence of Events

Hypoventilation → CO₂ retention → ↑PaCO₂ (primary disturbance)
↑PCO₂ drives: CO₂ + H₂O → H⁺ + HCO₃⁻ (mass action) → pH falls, HCO₃⁻ rises slightly
Buffering occurs exclusively in ICF - CO₂ diffuses into cells (especially RBCs), where it is converted to H⁺ + HCO₃⁻; H⁺ is buffered by intracellular proteins (hemoglobin) and organic phosphates
No respiratory compensation exists - respiration is the cause of the disorder
Renal compensation kicks in over 24-72 hours

There is no respiratory compensation for respiratory acidosis, since respiration is the cause of this disorder. - Costanzo Physiology 7th Ed.

Etiology / Causes

A. CNS Depression (Reduced Respiratory Drive)

Drugs: opioids/narcotics, benzodiazepines, barbiturates, general anesthetics, alcohol
Structural: stroke, head trauma, CNS tumors, CNS infections (encephalitis, meningitis)
Metabolic: severe hypothyroidism (myxedema coma)
Sleep-disordered breathing: obesity-hypoventilation syndrome (Pickwickian), primary alveolar hypoventilation (Ondine's curse), obstructive sleep apnea

B. Neuromuscular Disorders (Pump Failure)

Lower motor neuron: poliomyelitis, amyotrophic lateral sclerosis (ALS)
Neuromuscular junction: myasthenia gravis, botulism, organophosphate poisoning, neuromuscular blocking agents
Muscle diseases: muscular dystrophies, polymyopathy, severe hypokalemia/hypophosphatemia
Spinal cord injury: high cervical lesions (C3-C5 involvement paralyzes diaphragm)
Chest wall: kyphoscoliosis, flail chest, ankylosing spondylitis

C. Airway Obstruction

Upper airway: aspiration of foreign body, laryngospasm, angioedema, severe obstructive sleep apnea
Lower airway: severe acute asthma, COPD exacerbation, anaphylaxis, inhalational injury

D. Parenchymal / Gas Exchange Disease

COPD (chronic), severe pneumonia, ARDS, pulmonary edema
Pneumothorax, massive pleural effusion, atelectasis

E. Iatrogenic / Mechanical

Mechanical ventilation: inadequate rate/tidal volume settings, barotrauma, ET tube displacement
Permissive hypercapnia - intentional in ARDS management (low tidal volume ventilation)
High PEEP with reduced cardiac output (increases alveolar dead space)
CO₂ absorption during laparoscopy

Types: Acute vs. Chronic Respiratory Acidosis

This distinction is critical clinically and in exams.

Feature	Acute	Chronic
Duration	Minutes to hours	> 24-48 hours
Compensation	Cellular buffering only	Renal compensation fully active
pH	Markedly low (may be < 7.2)	Near-normal (partially compensated)
HCO₃⁻ rise per 10 mmHg ↑PCO₂	1 mEq/L	4 mEq/L (renal)
H⁺ rise per mmHg ↑PCO₂	0.8 nEq/L	0.3 nEq/L
Maximum HCO₃⁻	-	Usually ≤ 38 mEq/L
Clinical urgency	Life-threatening, may need intubation	Chronic adaptation, less acute danger
Example	Acute severe asthma, opioid OD	COPD, obesity-hypoventilation

Compensation: Renal Response

The kidney is the sole compensatory organ in respiratory acidosis.

Mechanism of renal compensation:

Increased H⁺ secretion in proximal tubule and collecting duct
Increased titratable acid excretion (H₂PO₄⁻)
Increased NH₄⁺ synthesis and excretion
Increased HCO₃⁻ synthesis and reabsorption (generates "new" bicarbonate)
Chloride is excreted in exchange for retained HCO₃⁻ → hypochloremia develops

Rules of Thumb (Expected Compensation):

$$\text{Acute: } \Delta HCO_3^- = \Delta PaCO_2 \times 0.1$$

$$\text{Chronic: } \Delta HCO_3^- = \Delta PaCO_2 \times 0.4$$

Clinical application example (COPD patient):

PaCO₂ = 70 mmHg (ΔPaCO₂ = +30 mmHg), HCO₃⁻ = 33 mEq/L (Δ = +9 mEq/L)
Expected acute compensation: +3 mEq/L
Expected chronic compensation: +12 mEq/L
Actual Δ = +9 mEq/L → between acute and chronic → partially compensated chronic respiratory acidosis

If the measured HCO₃⁻ rise is greater than predicted, a concurrent metabolic alkalosis is present. If less than predicted, a concurrent metabolic acidosis is present.

Clinical Features

Neurological (CO₂ Narcosis / Hypercapnic Encephalopathy)

CO₂ is a potent cerebral vasodilator - this drives many CNS manifestations:

Acute/rapid rise in PaCO₂: anxiety, dyspnea, confusion, psychosis, hallucinations → coma
Chronic hypercapnia: sleep disturbances, memory loss, daytime somnolence, personality changes
Motor: tremor, myoclonic jerks, asterixis (flapping tremor - a hallmark sign)
Signs mimicking raised ICP: headache, papilledema, abnormal reflexes, focal weakness
Severe acidemia (pH < 7.2): cardiac arrhythmias, reduced myocardial contractility

Cardiovascular

Peripheral vasodilation (CO₂ is a vasodilator) → warm, flushed skin, bounding pulse
Tachycardia (early); bradycardia and hypotension (severe)
Pulmonary vasoconstriction (hypoxia-driven) → cor pulmonale in chronic cases

Respiratory

Dyspnea, use of accessory muscles
Cyanosis (from associated hypoxemia)
Paradoxical abdominal movement (in neuromuscular failure)

Metabolic

Hyperkalemia: H⁺ shifts into cells in exchange for K⁺ (approximately 0.5 mEq/L rise in K⁺ per 0.1 unit fall in pH)
Hypochloremia (in chronic - Cl⁻ excreted by kidney to retain HCO₃⁻)

Diagnosis

Step 1: ABG Interpretation

Look at pH → acidemia (< 7.35) confirms acidosis
Look at PaCO₂ → elevated (> 45 mmHg) confirms respiratory cause
Look at HCO₃⁻ → elevated (compensation) or very low (mixed disorder)
Calculate expected compensation using rules of thumb
If compensation is appropriate → simple respiratory acidosis
If HCO₃⁻ is higher than expected → mixed respiratory acidosis + metabolic alkalosis
If HCO₃⁻ is lower than expected → mixed respiratory acidosis + metabolic acidosis

Step 2: Identify Acute vs. Chronic

ABG + clinical history (duration of symptoms, prior ABGs if available)

Step 3: Workup for Cause

Chest X-ray - first-line investigation
Pulmonary function tests (spirometry, DLCO, lung volumes) - if lung disease suspected
Drug history - always exclude opioids, sedatives
Hematocrit - anemia
Neurological assessment - if CNS cause suspected (CT head, MRI spine)
Neuromuscular assessment - NCS/EMG, acetylcholine receptor antibodies (myasthenia)
Polysomnography - if sleep-disordered breathing suspected

Treatment

Principles

The management depends on severity, rate of onset, and underlying cause.

1. Acute Respiratory Acidosis (Life-threatening)

Reverse the underlying cause simultaneously with restoration of ventilation
Tracheal intubation and mechanical ventilation if indicated
Treat bronchospasm (acute asthma): nebulized bronchodilators, IV corticosteroids, magnesium sulfate
Reverse opioid toxicity: naloxone (IV/IM/intranasal)
Reverse benzodiazepine toxicity: flumazenil

2. Oxygen Therapy - Special Caution in COPD

O₂ must be titrated carefully in chronic CO₂ retainers (COPD with chronic hypercapnia)
These patients rely on hypoxic drive; injudicious O₂ → removes hypoxic stimulus → further hypoventilation → worsening respiratory acidosis
Target SpO₂: 88-92% in chronic hypercapnic COPD (not 94-98%)
Non-invasive ventilation (NIV/BiPAP) is preferred over intubation in COPD exacerbation

3. Chronic Respiratory Acidosis

Aims at improving underlying lung function
Smoking cessation, bronchodilators, corticosteroids, diuretics (pulmonary edema), physiotherapy
Long-term NIV (BiPAP) at home for obesity-hypoventilation syndrome, neuromuscular disease
Treatment of sleep apnea: CPAP/BiPAP

4. Correction of PaCO₂ - Important Caveat

Avoid aggressive rapid correction of hypercapnia in chronic respiratory acidosis
Rapidly falling PaCO₂ → same complications as acute respiratory alkalosis: cardiac arrhythmias, seizures, reduced cerebral perfusion
Lower PaCO₂ gradually to baseline level (not necessarily normal)
Simultaneously provide adequate Cl⁻ and K⁺ to enable renal excretion of the retained HCO₃⁻

5. Permissive Hypercapnia (in ARDS/ICU)

Lung-protective ventilation uses low tidal volumes (6 mL/kg IBW) to prevent barotrauma
Allows PaCO₂ to rise (permissive hypercapnia)
Acceptable pH target: approximately 7.20-7.25
If concurrent metabolic acidosis, may require sodium bicarbonate infusion
Absolute contraindication: raised intracranial pressure (CO₂-driven vasodilation worsens ICP)

Summary: Key Points Table

Feature	Detail
Primary disturbance	↑ PaCO₂ (hypoventilation)
ABG pattern	pH ↓, PaCO₂ ↑, HCO₃⁻ ↑
Compensation	Renal (no respiratory compensation)
Acute HCO₃⁻ rise	1 mEq/L per 10 mmHg ↑PaCO₂
Chronic HCO₃⁻ rise	4 mEq/L per 10 mmHg ↑PaCO₂
Max HCO₃⁻ in compensation	~38 mEq/L
Classic signs	Asterixis, papilledema, CO₂ narcosis
Most common chronic cause	COPD
Most common acute cause	Opioid overdose / acute severe asthma
O₂ caution	Titrate carefully in chronic CO₂ retainers (target SpO₂ 88-92%)
Correction caution	Never correct chronic hypercapnia rapidly

Exam High-Yield Points

Respiratory acidosis = hypoventilation = CO₂ retention - any cause of reduced alveolar ventilation
No respiratory compensation - respiration IS the problem
Acute vs. chronic distinction is the most important clinical differentiation - use HCO₃⁻ rules of thumb
Asterixis is the hallmark neurological sign of CO₂ retention
Papilledema can occur due to CO₂-driven cerebral vasodilation
Hypochloremia develops in chronic cases as kidneys excrete Cl⁻ to retain HCO₃⁻
Hyperkalemia occurs due to H⁺/K⁺ exchange across cell membranes
COPD + O₂: target 88-92%, not 94-98% - hypoxic drive is critical
Permissive hypercapnia in ARDS: deliberate strategy, pH > 7.20 is acceptable
Mixed disorders: if HCO₃⁻ is too high → + metabolic alkalosis (e.g., vomiting + COPD); if too low → + metabolic acidosis (e.g., COPD + lactic acidosis from tissue hypoxia)

Remove dollar and give answer

Here is the same answer with all equation dollar signs removed and equations written in plain text:

Respiratory Acidosis — Full Answer for MD Respiratory Medicine Exam (10 Marks)

Definition

The fundamental equation governing this process:

CO₂ + H₂O ⇌ H₂CO₃ ⇌ H⁺ + HCO₃⁻

When CO₂ is retained, this reaction is driven to the right, generating excess H⁺ and lowering pH.

Henderson-Hasselbalch equation:

pH = 6.1 + log ( [HCO₃⁻] / 0.03 × PaCO₂ )

Kassirer-Bleich approximation (clinical bedside use):

[H⁺] = 24 × PaCO₂ / [HCO₃⁻]

Normal ABG Values (Reference)

Parameter	Normal Range
pH	7.35 - 7.45
PaCO₂	35 - 45 mmHg
HCO₃⁻	22 - 26 mEq/L
PaO₂	80 - 100 mmHg

In Respiratory Acidosis:

pH: ↓ (< 7.35)
PaCO₂: ↑ (primary disturbance)
HCO₃⁻: ↑ (compensatory)

Pathophysiology

Primary Mechanism

Causes reduce ventilation through four main mechanisms:

Depression of the medullary respiratory center - reduces drive to breathe
Impaired neuromuscular transmission - reduces mechanical ability to ventilate
Airway obstruction - increases resistance, reduces effective ventilation
Impaired gas exchange - CO₂ cannot exit pulmonary capillary blood into alveolar air

Sequence of Events

Hypoventilation → CO₂ retention → ↑PaCO₂ (primary disturbance)
↑PCO₂ drives: CO₂ + H₂O → H⁺ + HCO₃⁻ (mass action) → pH falls, HCO₃⁻ rises slightly
Buffering occurs exclusively in ICF - CO₂ diffuses into cells (especially RBCs), where it is converted to H⁺ + HCO₃⁻; H⁺ is buffered by intracellular proteins (hemoglobin) and organic phosphates
No respiratory compensation exists - respiration is the cause of the disorder
Renal compensation kicks in over 24-72 hours

There is no respiratory compensation for respiratory acidosis, since respiration is the cause of this disorder. - Costanzo Physiology 7th Ed.

Etiology / Causes

A. CNS Depression (Reduced Respiratory Drive)

Drugs: opioids/narcotics, benzodiazepines, barbiturates, general anesthetics, alcohol
Structural: stroke, head trauma, CNS tumors, CNS infections (encephalitis, meningitis)
Metabolic: severe hypothyroidism (myxedema coma)
Sleep-disordered breathing: obesity-hypoventilation syndrome (Pickwickian), primary alveolar hypoventilation (Ondine's curse), obstructive sleep apnea

B. Neuromuscular Disorders (Pump Failure)

Lower motor neuron: poliomyelitis, amyotrophic lateral sclerosis (ALS)
Neuromuscular junction: myasthenia gravis, botulism, organophosphate poisoning, neuromuscular blocking agents
Muscle diseases: muscular dystrophies, polymyopathy, severe hypokalemia/hypophosphatemia
Spinal cord injury: high cervical lesions (C3-C5 involvement paralyzes diaphragm)
Chest wall: kyphoscoliosis, flail chest, ankylosing spondylitis

C. Airway Obstruction

Upper airway: aspiration of foreign body, laryngospasm, angioedema, severe obstructive sleep apnea
Lower airway: severe acute asthma, COPD exacerbation, anaphylaxis, inhalational injury

D. Parenchymal / Gas Exchange Disease

COPD (chronic), severe pneumonia, ARDS, pulmonary edema
Pneumothorax, massive pleural effusion, atelectasis

E. Iatrogenic / Mechanical

Mechanical ventilation: inadequate rate/tidal volume settings, barotrauma, ET tube displacement
Permissive hypercapnia - intentional in ARDS management (low tidal volume ventilation)
High PEEP with reduced cardiac output (increases alveolar dead space)
CO₂ absorption during laparoscopy

Types: Acute vs. Chronic Respiratory Acidosis

Feature	Acute	Chronic
Duration	Minutes to hours	> 24-48 hours
Compensation	Cellular buffering only	Renal compensation fully active
pH	Markedly low (may be < 7.2)	Near-normal (partially compensated)
HCO₃⁻ rise per 10 mmHg ↑PCO₂	1 mEq/L	4 mEq/L (renal)
H⁺ rise per mmHg ↑PCO₂	0.8 nEq/L	0.3 nEq/L
Maximum HCO₃⁻	-	Usually ≤ 38 mEq/L
Clinical urgency	Life-threatening, may need intubation	Chronic adaptation, less acute danger
Example	Acute severe asthma, opioid OD	COPD, obesity-hypoventilation

Compensation: Renal Response

The kidney is the sole compensatory organ in respiratory acidosis.

Mechanism of renal compensation:

Increased H⁺ secretion in proximal tubule and collecting duct
Increased titratable acid excretion (H₂PO₄⁻)
Increased NH₄⁺ synthesis and excretion
Increased HCO₃⁻ synthesis and reabsorption (generates "new" bicarbonate)
Chloride is excreted in exchange for retained HCO₃⁻ → hypochloremia develops

Rules of Thumb (Expected Compensation):

Acute: Delta HCO₃⁻ = Delta PaCO₂ × 0.1

Chronic: Delta HCO₃⁻ = Delta PaCO₂ × 0.4

Clinical application example (COPD patient):

PaCO₂ = 70 mmHg (Delta PaCO₂ = +30 mmHg), HCO₃⁻ = 33 mEq/L (Delta = +9 mEq/L)
Expected acute compensation: +3 mEq/L
Expected chronic compensation: +12 mEq/L
Actual Delta = +9 mEq/L → between acute and chronic → partially compensated chronic respiratory acidosis

If the measured HCO₃⁻ rise is greater than predicted → concurrent metabolic alkalosis is present. If less than predicted → concurrent metabolic acidosis is present.

Clinical Features

Neurological (CO₂ Narcosis / Hypercapnic Encephalopathy)

CO₂ is a potent cerebral vasodilator - this drives many CNS manifestations:

Acute/rapid rise in PaCO₂: anxiety, dyspnea, confusion, psychosis, hallucinations → coma
Chronic hypercapnia: sleep disturbances, memory loss, daytime somnolence, personality changes
Motor: tremor, myoclonic jerks, asterixis (flapping tremor - a hallmark sign)
Signs mimicking raised ICP: headache, papilledema, abnormal reflexes, focal weakness
Severe acidemia (pH < 7.2): cardiac arrhythmias, reduced myocardial contractility

Cardiovascular

Peripheral vasodilation → warm, flushed skin, bounding pulse
Tachycardia (early); bradycardia and hypotension (severe)
Pulmonary vasoconstriction (hypoxia-driven) → cor pulmonale in chronic cases

Respiratory

Dyspnea, use of accessory muscles
Cyanosis (from associated hypoxemia)
Paradoxical abdominal movement (in neuromuscular failure)

Metabolic / Electrolytes

Hyperkalemia: H⁺ shifts into cells in exchange for K⁺ (approximately 0.5 mEq/L rise in K⁺ per 0.1 unit fall in pH)
Hypochloremia: in chronic - Cl⁻ excreted by kidney to retain HCO₃⁻

Diagnosis

Step 1: ABG Interpretation

pH < 7.35 → acidemia confirmed
PaCO₂ > 45 mmHg → respiratory origin confirmed
HCO₃⁻ elevated → compensation (or mixed disorder)
Calculate expected compensation using rules of thumb
Appropriate compensation → simple respiratory acidosis
HCO₃⁻ higher than expected → mixed respiratory acidosis + metabolic alkalosis
HCO₃⁻ lower than expected → mixed respiratory acidosis + metabolic acidosis

Step 2: Identify Acute vs. Chronic

ABG + clinical history (duration of symptoms, prior ABGs)

Step 3: Workup for Cause

Chest X-ray - first-line investigation
Pulmonary function tests (spirometry, DLCO, lung volumes)
Drug history - always exclude opioids, sedatives
Hematocrit - anemia
Neurological assessment - CT head, MRI spine if CNS cause suspected
Neuromuscular assessment - NCS/EMG, acetylcholine receptor antibodies (myasthenia gravis)
Polysomnography - if sleep-disordered breathing suspected

Treatment

1. Acute Respiratory Acidosis (Life-threatening)

Reverse the underlying cause simultaneously with restoration of ventilation
Tracheal intubation and mechanical ventilation if indicated
Treat bronchospasm (acute asthma): nebulized bronchodilators, IV corticosteroids, magnesium sulfate
Reverse opioid toxicity: naloxone (IV/IM/intranasal)
Reverse benzodiazepine toxicity: flumazenil

2. Oxygen Therapy - Special Caution in COPD

Must be titrated carefully in chronic CO₂ retainers
Injudicious O₂ → removes hypoxic drive → further hypoventilation → worsening respiratory acidosis
Target SpO₂: 88-92% in chronic hypercapnic COPD (not 94-98%)
Non-invasive ventilation (NIV/BiPAP) is preferred over intubation in COPD exacerbation

3. Chronic Respiratory Acidosis

Smoking cessation, bronchodilators, corticosteroids, diuretics, physiotherapy
Long-term NIV (BiPAP) at home for obesity-hypoventilation syndrome, neuromuscular disease
CPAP/BiPAP for obstructive sleep apnea

4. Correction of PaCO₂ - Important Caveat

Never correct chronic hypercapnia rapidly
Rapidly falling PaCO₂ → cardiac arrhythmias, seizures, reduced cerebral perfusion
Lower PaCO₂ gradually to the patient's own baseline, not necessarily to 40 mmHg
Provide adequate Cl⁻ and K⁺ to allow renal excretion of retained HCO₃⁻

5. Permissive Hypercapnia (in ARDS/ICU)

Low tidal volume ventilation (6 mL/kg IBW) to prevent barotrauma
Allows PaCO₂ to rise; acceptable pH target: approximately 7.20-7.25
Sodium bicarbonate infusion may be needed if concurrent metabolic acidosis
Absolute contraindication: raised intracranial pressure

Summary Table

Feature	Detail
Primary disturbance	↑ PaCO₂ (hypoventilation)
ABG pattern	pH ↓, PaCO₂ ↑, HCO₃⁻ ↑
Compensation	Renal only (no respiratory compensation)
Acute HCO₃⁻ rise	1 mEq/L per 10 mmHg ↑PaCO₂
Chronic HCO₃⁻ rise	4 mEq/L per 10 mmHg ↑PaCO₂
Max HCO₃⁻ in compensation	~38 mEq/L
Classic signs	Asterixis, papilledema, CO₂ narcosis
Most common chronic cause	COPD
Most common acute cause	Opioid overdose / acute severe asthma
O₂ caution	Target SpO₂ 88-92% in chronic CO₂ retainers
Correction caution	Never correct chronic hypercapnia rapidly

Exam High-Yield Points

Respiratory acidosis = hypoventilation = CO₂ retention
No respiratory compensation - respiration IS the problem
Acute vs. chronic distinction is the most important clinical differentiation
Asterixis is the hallmark neurological sign of CO₂ retention
Papilledema can occur due to CO₂-driven cerebral vasodilation
Hypochloremia develops in chronic cases - kidneys excrete Cl⁻ to retain HCO₃⁻
Hyperkalemia occurs due to H⁺/K⁺ exchange across cell membranes
COPD + O₂: target 88-92%, not 94-98%
Permissive hypercapnia in ARDS: deliberate strategy, pH > 7.20 acceptable
If HCO₃⁻ too high → mixed with metabolic alkalosis (e.g., vomiting + COPD); if too low → mixed with metabolic acidosis (e.g., COPD + lactic acidosis from tissue hypoxia)

This is a shared conversation. Sign in to Orris to start your own chat.